588 related articles for article (PubMed ID: 6459779)
1. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
Suenson E; Thorsen S
Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
[TBL] [Abstract][Full Text] [Related]
2. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
Anonick PK; Vasudevan J; Gonias SL
Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
4. Adsorption to fibrin of native fragments of known primary structure from human plasminogen.
Thorsen S; Clemmensen I; Sottrup-Jensen L; Magnusson S
Biochim Biophys Acta; 1981 May; 668(3):377-87. PubMed ID: 7236714
[TBL] [Abstract][Full Text] [Related]
5. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
Bok RA; Mangel WF
Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
[TBL] [Abstract][Full Text] [Related]
6. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
7. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
[TBL] [Abstract][Full Text] [Related]
8. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
Suenson E; Lützen O; Thorsen S
Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
Angles-Cano E; Rouy D; Lijnen HR
Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin.
Takada A; Takada Y
Thromb Res; 1989 Sep; 55(6):717-25. PubMed ID: 2551068
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
Müllertz S; Thorsen S; Sottrup-Jensen L
Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
[TBL] [Abstract][Full Text] [Related]
12. Effects of tranexamic acid on the conversion of Glu-plasminogen I and II to its Lys-forms.
Takada A; Takada Y
Thromb Res; 1985 Oct; 40(2):171-9. PubMed ID: 2933845
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor.
Petersen LC; Clemmensen I
Biochem J; 1981 Oct; 199(1):121-7. PubMed ID: 6175313
[TBL] [Abstract][Full Text] [Related]
14. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
Lucas MA; Straight DL; Fretto LJ; McKee PA
J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
[TBL] [Abstract][Full Text] [Related]
15. Interaction of staphylokinase with different molecular forms of plasminogen.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1993 Jan; 211(1-2):91-7. PubMed ID: 8425556
[TBL] [Abstract][Full Text] [Related]
16. [Features of the interaction of Glu- and Lys-forms of plasminogen with native and partially hydrolyzed fibrin].
Grinenko TV; Skomorovskaia EV; Kudinov SA; Zolotareva EN
Biokhimiia; 1992 May; 57(5):728-37. PubMed ID: 1322196
[TBL] [Abstract][Full Text] [Related]
17. Release of N-terminal peptides from Glu-plasminogen by plasmin in the presence of fibrin.
Takada A; Watahiki Y; Takada Y
Thromb Res; 1986 Mar; 41(6):819-27. PubMed ID: 2939588
[TBL] [Abstract][Full Text] [Related]
18. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
Takada A; Takada Y
Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
[TBL] [Abstract][Full Text] [Related]
19. Trinitrobenzoylated poly(D-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator.
Petersen LC; Suenson E
Biochim Biophys Acta; 1986 Sep; 883(2):313-25. PubMed ID: 2943320
[TBL] [Abstract][Full Text] [Related]
20. Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin.
Sakharov DV; Lijnen HR; Rijken DC
J Biol Chem; 1996 Nov; 271(44):27912-8. PubMed ID: 8910391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
